QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BAX

QT68Baxter International Inc.
NYSE·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
19.89
+0.50+2.58%
OverviewShort InterestFilings
BAXQT68Baxter International Inc.·NYSE
OverviewShort InterestFilings
19.89+2.58%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91ATR+0.28%$120.32RGEN-1.15%$132.02AVTR+1.27%$9.58
Snapshot
Index-P/E-EPS (ttm)-2.10
Insider Own0.77%
Shs Outstand516.47M
Perf Week-2.93%
Market Cap10.01BForward P/E9.98EPS next Y1.99Insider Trans0.00%Shs Float-Perf Month8.51%
Enterprise Value17.68BPEG0.13EPS next Q0.37Inst Own-Short Float-Perf Quarter19.39%
Income-1101576730.00P/S0.88EPS this Y191.43%Inst Trans-Short Ratio-Perf Half Y4.41%
Sales11.32BP/B1.65EPS next Y3.79%ROA-5.53%Short Interest-Perf YTD4.08%
Book/sh11.65P/C7.98EPS next 5Y5.82%ROE-16.43%52W High31.76 -37.37%Perf Year-33.52%
Cash/sh3.91P/FCF14.03EPS past 3/5Y-ROIC-1.77%52W Low15.73 26.45%Perf 3Y-
Dividend Est.0.20 (1.01%)EV/EBITDA23.96Sales past 3/5Y3.79% -0.75%Gross Margin30.11%Volatility2.26% 2.56%Perf 5Y-
Dividend TTM0.20 (1.01%)EV/Sales1.56EPS Y/Y TTM263.78%Oper. Margin-2.65%ATR (14)0.73Perf 10Y-
Dividend Ex-DateMay 29, 2026Quick Ratio1.23Sales Y/Y TTM6.43%Profit Margin-9.70%RSI (14)56.01Recom3.10
Dividend Gr. 3/5Y-23.25% -11.45%Current Ratio1.85EPS Q/Q-34.55%SMA201.80%Beta1.24Target Price20.71
Payout-24.23%Debt/Eq1.60Sales Q/Q2.90%SMA507.66%Rel Volume1.41Prev Close19.39
Employees38,000LT Debt/Eq1.63EarningsJul 30SMA2001.06%Avg Volume7.40MPrice19.89
IPO DateOct 27, 1981Option/ShortYes / YesEPS/Sales Surpr.16.13% 3.29%Net Debt/EBITDA10.39Volume10,439,985Change2.58%
Analyst Ratings
DateActionAnalystRatingTarget
May-28-26DowngradeCitigroupNeutral → Sell
May-04-26ReiteratedBarclaysOverweight$25 → $27
Feb-17-26ReiteratedGoldman SachsNeutral$23 → $17
Feb-16-26ReiteratedUBSNeutral$21 → $19
Feb-13-26ReiteratedDeutsche BankHold$22 → $20
Feb-13-26ReiteratedBarclaysOverweight$30 → $25
Feb-12-26ReiteratedJefferiesHold$21 → $19
Feb-12-26ReiteratedStifel NicolausHold$22 → $20
Jan-09-26ReiteratedGoldman SachsNeutral$22 → $23
Jan-09-26ReiteratedBarclaysOverweight$36 → $30
Latest News
Jun-18-26
Jun-18-2608:30PM
Global ECG Patch and Holter Monitor Market Size/Share Worth USD 3.92 Billion by 2035 at a 9.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo
05:30PM
Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)Yahoo
02:01PM
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization PlatformYahoo
Jun-17-26
Jun-17-2605:51PM
Is Baxter International Stock Underperforming the S&P 500?Yahoo
Jun-16-26
Jun-16-2606:14PM
Reasons to Retain Baxter International Stock in Your Portfolio for NowYahoo
Jun-15-26
Jun-15-2601:11AM
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value WarrantedYahoo
Jun-14-26
Jun-14-2606:04PM
Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround PlansYahoo
Jun-12-26
Jun-12-2612:13PM
3 Unpopular Stocks We’re Skeptical OfYahoo
Jun-11-26
Jun-11-2608:14PM
Is Baxter International Inc. (BAX) A Good Stock To Buy Now?Yahoo
01:05PM
FDA Issues Early Alert Regarding Pressure Breathing Device Issue from BaxterBenzinga
01:05PM
FDA Issues Early Alert Regarding Pressure Breathing Device Issue from BaxterBenzinga
Jun-10-26
Jun-10-2604:54PM
DaVita Stock Gains From Integrated Kidney Care and CKCC ProgressYahoo
04:01AM
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in DowngradeYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue11,32011,24410,636
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A7,9117,8656,652
Gross Profit3,4093,3793,984
Selling, General and Administrative Excl. Other2,9152,8902,967
Research and Development517518590
Other Operating Expense277279413
Operating Income-300-30814
Interest Expense287290408
Unusual Expense
———
Non-Operating Income (Expense)-67-93-105
Net Income Before Taxes-508-505-289
Income Taxes47339537
Consolidated Net Income-1,098-957-649
Net Income From Continuing Operations-981-900-326
Net Income-1,098-957-649
EPS (Recurring)-2.10-1.75-1.27
EPS (Basic, Before Extraordinaries)-2.10-1.75-1.27
EPS (Diluted)-2.10-1.75-1.27
EBITDA7387661,116
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.900.87—
Gross Margin30.1130.0537.46
Operating Margin-2.65-2.740.13
Net Margin-9.70-8.51-6.10
Shares Outstanding515513510
Market Capitalization10,2439,803—
Operating Lease Expense
———
Insider Trading Volume
$21.47$20.47$19.48$18.48$17.48● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Option Exercise37.17128,9764,794,038206,778Mar 05 12:00 AM
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Sale40.6164,4882,618,858142,290Mar 05 12:00 AM
STROUCKEN ALBERT P LDirectorMar 20 '23Option Exercise36.937,860290,27040,765Mar 22 12:00 AM
STROUCKEN ALBERT P LDirectorMar 20 '23Sale37.523,930147,45436,835Mar 22 12:00 AM
Kunzler JacquelineSVP, Chief Quality OfficerFeb 21 '23Option Exercise37.828,326314,89020,538Feb 23 12:00 AM
Kunzler JacquelineSVP, Chief Quality OfficerFeb 21 '23Sale40.503,813154,42716,725Feb 23 12:00 AM
Mason Jeanne KSVP, Human ResourcesJan 17 '23Option Exercise18.91118,9542,249,420185,708Jan 19 12:00 AM
Mason Jeanne KSVP, Human ResourcesJan 17 '23Sale44.7059,4772,658,622126,231Jan 19 12:00 AM
STROUCKEN ALBERT P LDirectorApr 05 '22Sale76.024,020305,61234,127Apr 07 12:00 AM
STROUCKEN ALBERT P LDirectorApr 05 '22Option Exercise19.6812,060237,34038,147Apr 07 12:00 AM
HELLMAN PETER Sdirector:Apr 05 '22Option Exercise29.528,040237,34031,649Apr 07 12:00 AM
HELLMAN PETER Sdirector:Apr 05 '22Sale76.024,020305,59427,629Apr 07 12:00 AM
FORSYTH JOHN Ddirector:Apr 01 '22Option Exercise0.001,00501,005Apr 05 12:00 AM
FORSYTH JOHN Ddirector:Apr 01 '22Sale77.681,00578,06827,029Apr 05 12:00 AM
FORSYTH JOHN DDirectorMar 01 '22Option Exercise29.522,01059,33628,034Mar 03 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR